AI-based Clinical Trials Solution Provider Market (By Clinical Trial Phase: Phase-I, Phase-II, Phase-III; By Therapeutic Application: Oncology, Cardiovascular Diseases, Neurological Diseases or Conditions, Metabolic Diseases, Infectious Diseases, Others; By End-user: Pharmaceutical Companies, Academia, Others) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 2030

The global AI-based Clinical Trials Solution Provider market size is expected to be worth around US$ 10.2 billion by 2030, according to a new report by Vision Research Reports.

The global AI-based Clinical Trials Solution Provider market size was valued at US$ 2.1 billion in 2020 and is anticipated to grow at a CAGR of 25.3% during forecast period 2021 to 2030.

Growth Factors

Supportive initiatives by the public and private sector for R&D with respect to various therapeutic areas, rising adoption of AI-based technologies among pharmaceutical companies and academia, and growing penetration of artificial intelligence (AI), are among the factors driving the market. In addition, increasing awareness and diverse applications provided by AI in the field of Clinical Trials  is further bolstering the growth.

Rising adoption of AI-based platforms and technologies by pharmaceutical companies and academia, along with increasing adoption of artificial intelligence (AI) are among the factors driving the market growth. In addition, increasing public and private sector offerings for boosting the research and development in various therapeutic areas, coupled with diverse applications provided by AI in the field of clinical Trials is further supporting the growth.

Report Highlights

The phase-II segment dominated the market for AI-based clinical trial solution providers and accounted for the largest revenue share of 58.5% in 2020. This high share is attributable to the increasing number of clinical trials active in the second phase. Furthermore, the immediate outcomes of the overall desired outcome through the clinical trials are analyzed in this phase, thereby boosting the adoption of AI-based tools for data collection and analysis. In addition, since the validation, improvement, and determination of measures with respect to the AI-based tool can be carried out in this phase, the segment comprises of higher revenue share as compared to other phases.

In 2020, based on therapeutic applications, the oncology segment dominated the market and accounted for the largest revenue share of 34.0% owing to the rising prevalence of cancer and a growing number of clinical trials in the oncology field. Furthermore, there has been an increase in the number of market players adopting oncology-based AI solutions for clinical trials, which is further expected to propel the growth of this segment. 

The pharmaceutical companies segment dominated the market for AI-based clinical trial solution providers and accounted for the largest revenue share of 76.9% in 2020 owing to the increasing adoption of AI-based technologies for drug development and clinical trials by major pharmaceutical players. In addition, strategic initiatives in the form of mergers and acquisitions, collaborations, partnerships are further boosting the market growth. 

In addition, the others segment is expected to witness the highest CAGR over the forecast period. With the growing use of AI by pharmaceutical companies, there is an increasing trend of adopting these solutions by others such as Contract Research Organizations (CROs), government agencies, etc. The increasing involvement of CROs and other organizations in the development and adoption of AI-based platforms and technologies, useful in drug discovery and development, along with clinical trials, is likely to boost market growth during the forecast period.

North America dominated the AI-based clinical trial solution providers market and accounted for the largest revenue share of 53.6% in 2020. This growth is owing to various factors including an increasing number of clinical trials in the region, rising adoption of AI-based technologies, a higher number of start-ups and AI in drug development based companies in the region, and increasing awareness regarding AI-based tools and technologies. In addition, favorable government initiatives and rising strategic initiatives by key players are driving the demand for AI-based clinical trial solutions in the region.

Report Coverage Details
Market Size US$ 10.2 billion by 2030
Growth Rate CAGR of 25.3% From 2021 to 2030
Base year 2020
Historic Data 2017 to 2020
Forecast Period 2021 to 2030
Segments Covered Clinical Trial Phase, Therapeutic Application, End User
Regional Scope North America, Europe, Asia Pacific, Latin America, Middle East & Africa (MEA)
Companies Mentioned Unlearn.AI, Inc.; Saama Technologies; Antidote Technologies, Inc.; Phesi; Deep 6 AI; Innoplexus;; Intelligencia; Median Technologies; Symphony AI; BioAge Labs, Inc.; AiCure, LLC; CONSILX; DEEP LENS AI; Halo Health Systems; Pharmaseal; Ardigen; Trials.Ai; Koneksa Health; Euretos; BioSymetrics; Google- Verily; GNS Healthcare; IBM Watson; Exscientia

Key Players 

  • Unlearn.AI, Inc.

  • Saama Technologies

  • Antidote Technologies, Inc.

  • Phesi

  • Deep 6 AI

  • Innoplexus


  • Intelligencia

  • Median Technologies

  • Symphony AI

  • BioAge Labs, Inc.

  • AiCure, LLC



  • Halo Health Systems

  • Pharmaseal

  • Ardigen

  • Trials.Ai

  • Koneksa Health

  • Euretos

  • BioSymetrics

  • Google- Verily

  • GNS Healthcare

  • IBM Watson

  • Exscientia

Market Segmentation

  • Clinical Trial Phase Outlook

    • Phase-I

    • Phase-II

    • Phase-III

  • Therapeutic Application Outlook 

    • Oncology

    • Cardiovascular Diseases

    • Neurological Diseases or Conditions

    • Metabolic Diseases

    • Infectious Diseases

    • Others

  • End-user Outlook

    • Pharmaceutical Companies

    • Academia

    • Others

  • Regional Outlook 

    • North America

      • U.S.

      • Canada

    • Europe

      • U.K.

      • Germany

      • Italy

      • France

      • Spain

      • Russia

    • Asia Pacific

      • Australia

      • China

      • Japan

      • South Korea

      • India

    • Latin America

      • Mexico

      • Brazil

      • Argentina

    • Middle East & Africa

      • South Africa

      • Saudi Arabia

      • UAE

The AI-based Clinical Trials Solution Provider market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of AI-based Clinical Trials Solution Provider market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global AI-based Clinical Trials Solution Provider market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the AI-based Clinical Trials Solution Provider market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted AI-based Clinical Trials Solution Provider market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the AI-based Clinical Trials Solution Provider capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of AI-based Clinical Trials Solution Provider by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global AI-based Clinical Trials Solution Provider market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major AI-based Clinical Trials Solution Provider market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of AI-based Clinical Trials Solution Provider market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the AI-based Clinical Trials Solution Provider industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

AI-based Clinical Trials Solution Provider market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to AI-based Clinical Trials Solution Provider market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of AI-based Clinical Trials Solution Provider market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new AI-based Clinical Trials Solution Provider market. These factors have benefited the growth of the global market for AI-based Clinical Trials Solution Provider. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for AI-based Clinical Trials Solution Provider. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of AI-based Clinical Trials Solution Provider are as follows:

  • History Year: 2017-2020
  • Base Year: 2021
  • Forecast Year 2021 to 2030

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Report Detail

Proceed To Buy

USD 3500
USD 7000